Clinical Trial Update: Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial completion evaluating CT327 ointment for psoriasis vulgaris, reporting on efficacy, safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CT327 Ointment (CT327)

Snippet

Sponsor: Creabilis SA | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED